DNMT3A and acute myeloid leukemia: The spectrum of gene mutations we observed is in agreement with previous studies and underlines the particularly high incidence of NPM1 (52%), DNMT3A (34%), and FLT3–ITD (25%) mutations in older patients with CN-AML.